Quest Diagnostics Incorporated is a clinical laboratory company based in the United States that provides diagnostic testing services. It performs routine and specialized medical tests on blood, tissue and other specimens, and reports results to physicians, hospitals, employers and patients. Its services support medical diagnosis, treatment decisions and health screening, and the company also offers related services such as clinical trials testing and healthcare analytics for organizations that need laboratory information.
Quest Diagnostics Incorporated is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code Q1UE34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #319 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendStrong
79/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average8.9%
From 52-week high-5.3%
MomentumFair
70/100
Typical recent returns for this exchange.
See the numbers →
3-month return3.1%
6-month return16.0%
12-month, skipping last month28.7%
Stability (higher is calmer)Strong
96/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)17.0%
Worst drawdown, 1 year (smaller is calmer)-5.6%
LiquidityWeak
4/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M BRL
Zero-volume days95.0%
IncomeWeak
27/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.0%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 474.32 – 612.15Daily closes, split-adjusted
Signals
50-day average598.07
200-day average532.24
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.87
Technical summary
Daily
Neutral
7 bullish · 1 neutral · 8 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
579.4
Bullish
EMA 10
580.3
Bearish
SMA 20
582.2
Bearish
EMA 20
584.2
Bearish
SMA 50
598.1
Bearish
EMA 50
585.2
Bearish
SMA 100
565.9
Bullish
EMA 100
569.6
Bullish
SMA 200
532.2
Bullish
EMA 200
542.6
Bullish
Oscillators (daily)
RSI (14)
20.57
Bullish
MACD (12, 26)
-5.12
Bearish
Momentum (12)
0.27
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
-31.31
Neutral
Pivot points (classic, last session)
S3
579.6
S2
579.6
S1
579.6
Pivot
579.6
R1
579.6
R2
579.6
R3
579.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
6.03 USD
Yield on today's price
1.04%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
5 Oct 2026
1.5543
7 Jul 2026
1.5295
2 Apr 2026
1.4946
12 Jan 2026
1.4546
2 Oct 2025
1.5076
4 Jul 2025
1.5597
4 Apr 2025
1.6097
13 Jan 2025
1.5484
3 Oct 2024
1.4950
5 Jul 2024
1.4648
5 Apr 2024
1.3550
16 Jan 2024
1.2261
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
